top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (224 p.)
Soggetto topico Medicine
Pharmaceutical industries
Soggetto non controllato acute kidney injury
early biomarker
plasma neutrophil gelatinase-associated lipocalin
soluble urokinase plasminogen activator receptor
medication optimization
older patients
emergency department
multimorbidity
polypharmacy
potentially inappropriate medication use
older adults
prevalence
determinants
chronic
outpatient
2019 Beers criteria
Ethiopia
pharmacogenomics
persons with diabetes
drug–drug interactions
drug–gene interactions
cytochrome P450
SLCO1B1
drug interaction checkers
adverse drug reactions
pharmacogenetics
personalized medicine
phenprocoumon
DOACs
bleeding
thromboembolism
HLA
drug hypersensitivity
abacavir
allopurinol
flucloxacillin
antiepileptic drugs
cost-effectiveness
shared medication record
medication reconciliation
drug information service
hospital pharmacy service
electronic prescribing
electronic medical record
clinical pharmacist
CYP2D6
CYP2D7P
CYP2D8P
copy number variation
CNV
genotyping
5’nuclease assay
HRM
high resolution melting
drug metabolization
extracellular vesicles
exosomes
microvesicles
pharmacogene expression
medication review
deprescriptions
quality of life
aged
aged, 80 and over
nursing homes
deprescribing
medication-based risk score
health outcomes
cytochromes
CYP1A2
adverse drug reaction
antipsychotics
olanzapine
clozapine
loxapine
children
youth
digital decision-support
health services research
general practice
process evaluation
antidepressants
utility
population-based
appropriateness
medication adherence
digital health
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
Autore Ferroni Patrizia
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (202 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato multiple myeloma
venous thromboembolism
risk assessment models
thromboprophylaxis
direct oral anticoagulants
cancer-associated venous thromboembolism
thrombosis
pulmonary embolism
neoplasms
anticoagulants
coumarins
low molecular weight heparins
cancer
endogenous heparin
heparanase
heparan sulfate
hospice
palliative care units
low molecular weight heparin
deep vein thrombosis
cancer associated thrombosis
VTE
malignancy
direct oral anticoagulant
pancreatic cancer
low-molecular weight heparin
survival
coagulation activation
locally advanced breast cancer
prognostic model
pCR
treatment
prophylaxis
DOAC
simultaneous care
integrated care
lymphoma
Non-Hodgkin lymphoma
Hodgkin lymphoma
risk factors
molecular subtype
arterial thrombosis
ALK
ROS1
KRAS
chemotherapy
low-molecular-weight heparin (LMWH)
VKA
UFH
DOACs
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585935803321
Ferroni Patrizia  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui